Cargando…

CAPG Is Required for Ebola Virus Infection by Controlling Virus Egress from Infected Cells

The replication of Ebola virus (EBOV) is dependent upon actin functionality, especially at cell entry through macropinocytosis and at release of virus from cells. Previously, major actin-regulatory factors involved in actin nucleation, such as Rac1 and Arp2/3, were shown important in both steps. How...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mori, Hiroyuki, Connell, James P., Donahue, Callie J., Boytz, RuthMabel, Nguyen, Yen Thi Kim, Leung, Daisy W., LaCount, Douglas J., Davey, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505868/ https://www.ncbi.nlm.nih.gov/pubmed/36146710 http://dx.doi.org/10.3390/v14091903

Ejemplares similares

Inactivation of Ebola Virus and SARS-CoV-2 in Cell Culture Supernatants and Cell Pellets by Gamma Irradiation
por: Boytz, RuthMabel, et al.
Publicado: (2022)

Structure of the Inmazeb cocktail and resistance to Ebola virus escape
por: Rayaprolu, Vamseedhar, et al.
Publicado: (2023)

Host and Viral Proteins Modulating Ebola and Marburg Virus Egress
por: Gordon, Tamsin B., et al.
Publicado: (2019)

CAPG: comprehensive allopolyploid genotyper
por: Kulkarni, Roshan, et al.
Publicado: (2022)

Development of Monoclonal Antibodies to Detect for SARS-CoV-2 Proteins
por: Mishra, Nawneet, et al.
Publicado: (2022)

Monoclonal antibodies binding data for SARS-CoV-2 proteins
por: Mishra, Nawneet, et al.
Publicado: (2022)

Interferon-γ Inhibits Ebola Virus Infection
por: Rhein, Bethany A., et al.
Publicado: (2015)

Proteasome Inhibition Suppresses Dengue Virus Egress in Antibody Dependent Infection
por: Choy, Milly M., et al.
Publicado: (2015)

Novel amodiaquine derivatives potently inhibit Ebola virus infection
por: Sakurai, Yasuteru, et al.
Publicado: (2018)

Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritization
por: Patten, J.J., et al.
Publicado: (2022)

Multiple Routes of Bluetongue Virus Egress
por: Labadie, Thomas, et al.
Publicado: (2020)

Microtubules in Influenza Virus Entry and Egress
por: Simpson, Caitlin, et al.
Publicado: (2020)

Therapy of Ebola and Marburg virus infections
por: Bray, Mike
Publicado: (2006)

Membrane binding and bending in Ebola VP40 assembly and egress
por: Stahelin, Robert V.
Publicado: (2014)

A novel polypeptide CAPG-171aa encoded by circCAPG plays a critical role in triple-negative breast cancer
por: Song, Runjie, et al.
Publicado: (2023)

Modeling Challenges of Ebola Virus–Host Dynamics during Infection and Treatment
por: Chertow, Daniel S., et al.
Publicado: (2020)

A Loop Region in the N-Terminal Domain of Ebola Virus VP40 Is Important in Viral Assembly, Budding, and Egress
por: Adu-Gyamfi, Emmanuel, et al.
Publicado: (2014)

Comparisons of CapG and gelsolin-null macrophages: demonstration of a unique role for CapG in receptor-mediated ruffling, phagocytosis, and vesicle rocketing
por: Witke, Walter, et al.
Publicado: (2001)

An immunotoxin targeting Ebola virus glycoprotein inhibits Ebola virus production from infected cells
por: Cai, Yingyun, et al.
Publicado: (2021)

Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection
por: Lane, Thomas R., et al.
Publicado: (2019)

Requirements for Human Respiratory Syncytial Virus Glycoproteins in Assembly and Egress from Infected Cells
por: Batonick, Melissa, et al.
Publicado: (2011)

Archaeal viruses at the cell envelope: entry and egress
por: Quemin, Emmanuelle R. J., et al.
Publicado: (2015)

Egress of non-enveloped enteric RNA viruses
por: Owusu, Irene A., et al.
Publicado: (2021)

Animal models for Ebola and Marburg virus infections
por: Nakayama, Eri, et al.
Publicado: (2013)

Ebola virus infection modeling and identifiability problems
por: Nguyen, Van Kinh, et al.
Publicado: (2015)

Ebola Virus Infection: What Should Be Known?
por: Wiwanitkit, Viroj
Publicado: (2014)

Host Transcriptional Response to Ebola Virus Infection
por: Speranza, Emily, et al.
Publicado: (2017)

Ebola virus (EBOV) infection: Therapeutic strategies
por: De Clercq, Erik
Publicado: (2015)

Therapeutic Strategies against Ebola Virus Infection
por: Liu, Ching-Hsuan, et al.
Publicado: (2022)

Difference in phenotypic severity of presumed null alleles of capg-1
por: VanDiepenbos, Sarah, et al.
Publicado: (2020)

Super-enhancer-associated gene CAPG promotes AML progression
por: Ma, Qian, et al.
Publicado: (2023)

Pooled Analysis of the Accuracy of Xpert Ebola Assay for Diagnosing Ebola Virus Infection
por: Pan, Zhi-Yong, et al.
Publicado: (2021)

A Novel Proximity Biotinylation Assay Based on the Self-Associating Split GFP1–10/11
por: Kesari, Aditi S., et al.
Publicado: (2020)

A Polarized Cell Model for Chikungunya Virus Infection: Entry and Egress of Virus Occurs at the Apical Domain of Polarized Cells
por: Lim, Pei Jin, et al.
Publicado: (2014)

Non-Lytic Egression of Infectious Bursal Disease Virus (IBDV) Particles from Infected Cells
por: Méndez, Fernando, et al.
Publicado: (2017)

Comparative pathogenesis of Ebola virus and Reston virus infection in humanized mice
por: Escudero-Pérez, Beatriz, et al.
Publicado: (2019)

Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection
por: Marzi, Andrea, et al.
Publicado: (2016)

Cryo-EM analysis of Ebola virus nucleocapsid-like assembly
por: Wang, Yan, et al.
Publicado: (2021)

Naturally Occurring Single Mutations in Ebola Virus Observably Impact Infectivity
por: Wong, Gary, et al.
Publicado: (2018)

Risk for Ebola virus infection in Côte d'Ivoire.
por: Kunii, O, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_arpp81983cjkhh6dmus7av04e5